fda compounding semaglutide crackdown news today The is cracking down on ‘misleading’ compounded GLP-1s from telehealth companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, May 18, 2026: FDA warns

For years, the cost of Ozempic (semaglutide) has been a barrier for many Canadians managing type 2 diabetes

Simple, bland foods like crackers or rice can settle your stomach if nausea strikes

This could lead to issues like bacterial contamination, impurities, and the use of lower-grade ingredients

however, the precise contribution of glucagon receptor activation to the overall gastrointestinal side effect burden in humans has not yet been established, and this remains an area of active investigation

The FDA proposed in April 2026 to exclude semaglutide and tirzepatide from the 503B compounding bulks list - a development with real program availability implications that needs a direct answer from IVY RX before you commit to a multi-month plan

The pens also have to be kept refrigerated